Thursday, March 06, 2008

Hormone Replacement Therapy: Cancer Risk Stays

Menopausal women who took estrogen and progesterone do risk cancer for more than two years after the drug ingestion ended, according to the most recent results of a government study that has revealed a series of sobering findings about the once-popular hormone therapy.

The study of more than 15,000 women who took the hormones for more than five years found that the chance of developing cancer remained elevated well after they quit, which many did after an earlier stage of the study showed that the risks outweighed the benefits.

For more go to the WaPo report here.